Candriam SCA’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $174M | Sell |
347,426
-6,661
| -2% | -$3.2M | 0.78% | 22 |
|
|
2026
Q1 | $174M | Buy |
354,087
+56,368
| +19% | +$30.6M | 0.9% | 18 |
|
|
2025
Q4 | $173M | Buy |
297,719
+25,605
| +9% | +$14.5M | 0.86% | 17 |
|
|
2025
Q3 | $132M | Sell |
272,114
-65,359
| -19% | -$30.4M | 0.69% | 25 |
|
|
2025
Q2 | $137M | Sell |
337,473
-84,881
| -20% | -$35.5M | 0.79% | 22 |
|
|
2025
Q1 | $210M | Buy |
422,354
+14,864
| +4% | +$8.05M | 1.32% | 10 |
|
|
2024
Q4 | $212M | Buy |
407,490
+78,512
| +24% | +$43.2M | 1.22% | 11 |
|
|
2024
Q3 | $203M | Sell |
328,978
-102,680
| -24% | -$60.8M | 1.17% | 12 |
|
|
2024
Q2 | $239M | Buy |
431,658
+4,571
| +1% | +$2.62M | 1.45% | 8 |
|
|
2024
Q1 | $248M | Sell |
427,087
-68,180
| -14% | -$38.3M | 1.59% | 7 |
|
|
2023
Q4 | $263M | Buy |
495,267
+37,855
| +8% | +$18.3M | 1.81% | 6 |
|
|
2023
Q3 | $232M | Sell |
457,412
-8,595
| -2% | -$4.58M | 1.64% | 11 |
|
|
2023
Q2 | $243M | Buy |
466,007
+13,304
| +3% | +$7.18M | 1.76% | 5 |
|
|
2023
Q1 | $240M | Buy |
452,703
+13,509
| +3% | +$7.61M | 1.67% | 6 |
|
|
2022
Q4 | $242M | Buy |
439,194
+11,330
| +3% | +$6M | 1.63% | 9 |
|
|
2022
Q3 | $217M | Buy |
427,864
+23,598
| +6% | +$13.2M | 1.53% | 9 |
|
|
2022
Q2 | $220M | Buy |
404,266
+20,224
| +5% | +$11.1M | 1.81% | 8 |
|
|
2022
Q1 | $227M | Sell |
384,042
-36,750
| -9% | -$21.1M | 1.54% | 7 |
|
|
2021
Q4 | $281M | Buy |
420,792
+54,977
| +15% | +$34.3M | 1.79% | 5 |
|
|
2021
Q3 | $209M | Buy |
365,815
+12,692
| +4% | +$6.97M | 1.42% | 8 |
|
|
2021
Q2 | $178M | Sell |
353,123
-12,703
| -3% | -$5.99M | 1.22% | 8 |
|
|
2021
Q1 | $164M | Sell |
365,826
-6
| -0% | -$2.86K | 1.36% | 10 |
|
|
2020
Q4 | $170M | Buy |
365,832
+16,594
| +5% | +$7.78M | 1.35% | 10 |
|
|
2020
Q3 | $154M | Buy |
349,238
+82,897
| +31% | +$34.2M | 1.45% | 9 |
|
|
2020
Q2 | $96.5M | Buy |
266,341
+112,713
| +73% | +$37.8M | 1.02% | 14 |
|
|
2020
Q1 | $48.8M | Buy |
153,628
+29
| +0% | +$9.14K | 0.54% | 37 |
|
|
2019
Q4 | $49.9M | Buy |
153,599
+49,530
| +48% | +$15M | 0.53% | 37 |
|
|
2019
Q3 | $30.3M | Buy |
104,069
+10,569
| +11% | +$3.03M | 0.4% | 49 |
|
|
2019
Q2 | $27.3M | Buy |
93,500
+20,429
| +28% | +$5.63M | 0.34% | 60 |
|
|
2019
Q1 | $20M | Sell |
73,071
-14,335
| -16% | -$3.57M | 0.26% | 88 |
|
|
2018
Q4 | $19.6M | Buy |
87,406
+7,788
| +10% | +$1.83M | 0.3% | 69 |
|
|
2018
Q3 | $19.4M | Buy |
79,618
+22,488
| +39% | +$5.17M | 0.26% | 93 |
|
|
2018
Q2 | $11.8M | Buy |
57,130
+9,202
| +19% | +$1.95M | 0.19% | 140 |
|
|
2018
Q1 | $9.9M | Buy |
47,928
+698
| +1% | +$147K | 0.17% | 161 |
|
|
2017
Q4 | $8.97M | Buy |
47,230
+406
| +0.9% | +$77.8K | 0.16% | 169 |
|
|
2017
Q3 | $8.86M | Sell |
46,824
-5,440
| -10% | -$985K | 0.15% | 171 |
|
|
2017
Q2 | $9.12M | Sell |
52,264
-3,989
| -7% | -$670K | 0.17% | 157 |
|
|
2017
Q1 | $8.64M | Sell |
56,253
-37,194
| -40% | -$5.68M | 0.17% | 158 |
|
|
2016
Q4 | $13.2M | Buy |
93,447
+3,420
| +4% | +$504K | 0.3% | 88 |
|
|
2016
Q3 | $14.3M | Buy |
90,027
+5,621
| +7% | +$866K | 0.34% | 73 |
|
|
2016
Q2 | $12.5M | Buy |
84,406
+46,586
| +123% | +$6.88M | 0.32% | 79 |
|
|
2016
Q1 | $5.33M | Buy |
37,820
+3,190
| +9% | +$428K | 0.13% | 179 |
|
|
2015
Q4 | $4.91M | Sell |
34,630
-47,913
| -58% | -$6.39M | 0.13% | 182 |
|
|
2015
Q3 | $10.1M | Buy |
82,543
+4,167
| +5% | +$543K | 0.25% | 121 |
|
|
2015
Q2 | $10.2M | Buy |
78,376
+37,748
| +93% | +$4.92M | 0.21% | 138 |
|
|
2015
Q1 | $5.46M | Buy |
40,628
+5,460
| +16% | +$704K | 0.11% | 240 |
|
|
2014
Q4 | $4.41M | Buy |
+35,168
| New | +$4.28M | 0.09% | 255 |
|
Other funds holding TMO
Candriam SCA's TMO Position: Q2 2026 in Review
Candriam SCA reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $3.2M and leaving 347,426 shares worth $174M. The position accounts for 0.78% of the portfolio, ranked #22.
Candriam SCA first reported a position in TMO in Q4 2014 and has held it in 47 quarters since. The position peaked at $281M in Q4 2021. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Candriam SCA held 347,426 shares of Thermo Fisher Scientific worth $174M as of Q2 2026.
- Candriam SCA sold 6,661 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.2M.
- Thermo Fisher Scientific made up 0.78% of Candriam SCA's portfolio in Q2 2026, its #22 holding.
- Candriam SCA first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Thermo Fisher Scientific position peaked at $281M in Q4 2021.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.